Showing 1 - 20 results of 53 for search 'David D Ho', čas poizvedbe: 0.07s
Refine Results
-
1
-
2
Correction: A Shot in the Arm for AIDS Vaccine Research. od David D Ho
Izdano 2005-08-01
Article -
3
Engineering multi-specific antibodies against HIV-1 od Neal N. Padte, Jian Yu, Yaoxing Huang, David D. Ho
Izdano 2018-08-01
Article -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern od Qian Wang, Manoj S. Nair, Saumya Anang, Shijian Zhang, Hanh Nguyen, Yaoxing Huang, Lihong Liu, David D. Ho, Joseph G. Sodroski
Izdano 2021-11-01
Article -
12
-
13
-
14
-
15
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections od Chasity D. Andrews, Yang Luo, Ming Sun, Jian Yu, Arthur J. Goff, Pamela J. Glass, Neal N. Padte, Yaoxing Huang, David D. Ho
Izdano 2017-12-01
Article -
16
10E8V2.0/iMab: an engineered membrane-anchored bispecific anti-HIV antibody effective in preventing and treating HIV in humanized mice od Anastasia Lanzi, Yaoxing Huang, Jian Yu, Xin Yao, Chasity D. Andrews, Lily Tsai, Mili R. Gajjar, Michael S. Seaman, Neal N. Padte, David D. Ho
Izdano 2016-05-01
Article -
17
-
18
-
19
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 od Qian Wang, Zhiteng Li, Yicheng Guo, Ian A. Mellis, Sho Iketani, Michael Liu, Jian Yu, Riccardo Valdez, Adam S. Lauring, Zizhang Sheng, Aubree Gordon, Lihong Liu, David D. Ho
Izdano 2023-11-01
Article -
20
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors od Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho
Izdano 2021-05-01
Article